7月16日，Elevance Health盘中下跌3.03%，报370.162美元/股，成交额2.17亿美元。公司延续前一交易日财报公布后的跌势，持续承压。
消息面上，公司7月15日发布的Q2财报虽大幅超预期（调整后EPS 7.45美元 vs 预期6.21美元），但营业利润率从去年同期4.9%骤降至3.5%，EPS同比下降15.72%。此外，截至6月底医疗会员总数4490万，环比及同比分别下降1%及1.5%，CEO在电话会议中表示未来12至18个月将退出更多州的医疗补助市场。全年指引仅小幅上调至调整后EPS至少27美元，未能有效提振信心。尽管同行业联合健康当日上涨5.55%，但ELV因自身利润率压缩及医疗补助业务结构性隐忧持续遭到抛售。
（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.